GlassScriptPhysician profile
Romeo Massoud
NPI 1194875237
$26,859.83
in general payments reported to CMS, 2019-2025
41 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $184 · 2021: $413 · 2022: $8,186 · 2023: $841 · 2024: $1,965 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,906 · Travel and Lodging: $968 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,850.00 |
| Food and Beverage | $3,906.38 |
| Travel and Lodging | $968.26 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $16,450.89 | 2022-2025 | |
| Intuitive Surgical, INC. | $7,158.45 | 2019-2024 | |
| Stryker Corporation | $511.36 | 2022 | |
| Integra Lifesciences Corporation | $382.66 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $354.92 | 2021-2025 | Novosorb Btm |
| Tela Bio, INC. | $328.18 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kci USA, INC. | $155.16 | 2019-2023 | Abthera Advance |
| Baxter Healthcare | $128.89 | 2021-2025 | Perclot, Seprafilm |
| Ethicon US, LLC | $125.21 | 2020-2025 | Enseal |
| Lexington Medical, INC. | $106.81 | 2022 | |
| Alexion Pharmaceuticals, INC. | $96.84 | 2020-2022 | |
| Portola Pharmaceuticals, LLC | $91.82 | 2019-2020 | |
| Depuy Synthes Sales INC. | $86.36 | 2025 | Matrixrib |
| Prytime Medical Devices, INC. | $79.62 | 2024 | Er-Reboa Plus |
| Z-Medica, LLC | $70.71 | 2019-2020 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $67.85 | 2023-2024 | Andexxa |
| Access Pro Medical, LLC | $66.57 | 2025 | Matriderm |
| Kerecis Limited | $61.41 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $52.45 | 2022-2023 | |
| Teleflex LLC | $36.10 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.53 | 2022-2025 | Gattex |
| Medline Industries LP | $34.55 | 2019 | |
| Kls-Martin L.P. | $30.52 | 2024 | |
| Solventum Corporation | $27.47 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Haemonetics Corporation | $23.84 | 2019 | |
| Lifenet Health | $23.55 | 2023 | |
| Organogenesis INC. | $23.20 | 2021 | |
| Biom'Up Sa | $23.03 | 2019 | |
| Octapharma USA, INC. | $22.94 | 2025 | Fibryga |
| Biom'Up France Sas | $21.92 | 2020 | |
| Boston Scientific Corporation | $20.13 | 2025 | Spyglass Discover |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Avita Medical Americas, LLC | $19.74 | 2025 | Cohealyx, Recell, Permeaderm |
| Acell, INC. | $18.65 | 2019 | |
| Innocoll Pharmaceuticals Limited | $18.56 | 2022 | |
| Convatec INC. | $15.95 | 2022 | |
| Smith+Nephew, INC. | $15.42 | 2025 | Grafix Pl, Stravix |
| Acera Surgical, INC. | $15.38 | 2019 | |
| Hydrofera LLC | $15.06 | 2024 | Hydrofera Blue |
| Allergan, INC. | $13.13 | 2019 | |
| Reprise Biomedical, INC. | $9.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Romeo Massoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.